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ABSTRACT 
Objective:  The term prodrug involves chemically modifying inert compound which upon administration releases the active parent drug to elicit its 
pharmacological response within the body. Acting as a α-adrenergic agonist, desglymidodrine an active metabolite of amide prodrug midodrine is 
used for the treatment of essential and orthostatic hypotension. In the present study synthesis of desglymidodrine from midodrine was reported.  
Methods:  The synthesis was done by the conventional amide hydrolysis method.  
Results:  A novel synthesis of desglymidodrine was successfully achieved and spectrally elucidated by infrared spectroscopy (IR), 1H, 13C nuclear 
magnetic resonance (NMR) and mass analysis. 
Conclusion:  The acquired results were found to be accurate, the synthetic route appeared to be simple, cost-effective and time efficient. Hence the 
synthesized desglymidodrine can be as a reference standard for the estimation of the same. 
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Midodrine (N-glycyl derivative of Desglymidodrine), consisting of 
glycine promoiety linking to the amine group, undergoes enzymatic 
deglycination to give desglymidodrine. Desglymidodrine is α-adrenergic 
receptor agonist which increases the vascular tone and causes elevation 
of blood pressure [1]. Chemically midodrine is 2-amino-N-[2-(2, 5-
dimethoxyphenyl)-2-hydroxyethyl] acetamide. It has an empirical 
formula of C12H18N2O4 and a molecular weight of 254.28 g/mol [2]. 
The literature survey revealed different simultaneous estimation 
techniques like HPLC [3-6], Spectrometric [7], HPTLC [8] and to the 
best of our knowledge, plasma estimation in healthy human 
volunteers by UPLC-MS/MS [9] and ascetic patients using liquid 
chromatography-tandem mass spectroscopy [10] have been 
reported earlier. However, despite the significance of these 
analytical efforts in the simultaneous estimation of both prodrug 
and its active metabolite no synthetic route has been reported in the 
literature for the synthesis of desglymidodrine.  
Midodrine is a glycinamide prodrug consisting of a secondary amide 
linkage between glycine and desglymidodrine. The possible 
mechanism involves attack of hydroxide anion towards positively 
charged carbonyl carbon causing localization of the pi bond to 
carbonyl oxygen. This leads to the formation of a tetrahedral 
intermediate which eventually generates neutral amine and glycine 
anion. Here the amide linkage was cleaved by approaching 
conventional amide hydrolysis method under basic conditions 
giving desglymidodrine.  
The midodrine hydrochloride reference standard was supplied by 
PAR formulations, Chennai synthetic work was done by procuring 
analytical grade solvents. TLC was performed to monitor the 
reaction and to determine the purity of the sample product. The 
melting point of the synthesized compounds was determined in 
open capillaries using veego VMP-1 apparatus and expressed in ˚C 
and are uncorrected. The IR spectrum of compounds was recorded 
on Shimadzu FT-IR spectrometer using KBr pellet technique and is 
expressed in cm-1. 1H-NMR and 13C-NMR spectra were recorded on 
the Agilent (400MHz FT-NMR) using Vnmrj 3.2 V as processing 
software. Mass spectra were recorded with Shimadzu LC-MS/MS 
8030 system using lab solution software. DSC analysis was carried 
out by DSC Q 200 system. 
To a solution of midodrine hydrochloride (3 g, 0.01M) in 1N NaOH 
solution (200 ml) was refluxed in a water bath for 30 h. The 
completion of the reaction was monitored by TLC (n-butanol:  water, 
4.5:0.5 v/v) and LC-MS/MS. White crystals of desglymidodrine were 
obtained upon the addition of sodium hydroxide (q. s) which was 
























Fig. 1: Synthesis of desglymidodrine from midodrine 
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Yield = 96%, White crystalline, mp:  148-151  °C, IR (KBr) (υ in cm-1) 
= 3628.22 (OH str), 3350.46 and 3390.97 (NH2 str), 2992.66 and 
2935.76 (Aliphatic CH str), 1279.81 (C-O str), 3121 (Ar C-H str); 1H 
NMR (400 MHz, DMSO-d6, δ ppm): 4.71 (s, 1H, OH), 2.67 (s, 2H,-
NH2), 1.73 (s, 3H,-OCH3), 1.60 (s, 3H,-OCH3), 6.69-6.94 (m,3H, Ar-H) 
ppm;  [13] C NMR (400 MHz, DMSO-d6, δ ppm): 39.33, 40.62, 49.02, 
56.22, 111.88, 112.1, 113.14, 133.99, 150.18, 153.62 ppm;  MS (ESI) 
m/z (%): 198.05 [M+H]+. 
Midodrine hydrochloride was hydrolyzed into desglymidodrine in the 
presence of basic medium and the IR spectra (fig. 2), of synthesized 
compound, have shown-OH stretching at 3628.22 cm1, symmetrical and 
unsymmetrical N-H stretching bands at 3350.46 cm-1 and 3390.97 cm-1, 
aryl aliphatic ether C-O-C stretching at 1279.81 cm-1, aromatic C-H 
stretching band at 3121 cm-1, aliphatic symmetrical and unsymmetrical 
stretching at 2992.66 and 2935.76 cm-1. A highly intense molecular ion 




Fig. 2: IR spectra and scan mass spectra of synthesized desglymidodrine 
 
In the 1H NMR spectrum (fig. 3), singlet signals at δH 4.71 and 2.67 
revealed the presence of Hydroxyl and amino protons respectively. 
Two singlets at δH 1.73 and 1.60 represent six methoxyl protons 
along with multiplet signals at δH 6.6-6.9 for aromatic protons. In 13C 
NMR spectrum (fig. 3), signals at δC 69.19 and 49.02 indicate the 
presence of carbinolic carbon and carbon attached to an amine 
respectively. Two methoxy carbons are attributed to signals at δC 
55.68 and 56.22. The percentage purity of the synthesized 
compound was found to be 96.89 %, which was estimated by DSC 
analysis as shown in fig. 4. 
 
 
Fig. 3: NMR (1H) and (13C) analytical data for synthesized desglymidodrine 
 
 
Fig. 4: DSC analysis of synthesized desglymidodrine 
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Apparently, the present work previews the first reported method for 
synthesis of desglymidodrine from midodrine using conventional 
amide hydrolysis method. The formation of desglymidodrine was 
observed in mass spectrum as a gradual rise in the intensity of the 
peak at 198.05 m/z with respect to time. The spectral interpretation 
of synthesized desglymidodrine by IR, 1H and 13C NMR, the mass 
analysis showed consistency with the assigned structure, whereas 
the obtained purity by DSC explains the practical applicability of this 
synthesis method. Despite its applicability as a standard in 
numerous bio-analytical estimation methods the high cost of 
desglymidodrine and its availability in synthetic form seems to be a 
bottleneck for the budding researchers, where the current 
developed synthetic route appeared to be simple, cost-effective and 
time efficient.  
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